{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:59:51Z","timestamp":1792799991504,"version":"4.5.0"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s43032-025-01789-8","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T20:48:54Z","timestamp":1738097334000},"page":"618-646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses"],"prefix":"10.1007","volume":"32","author":[{"given":"Ilmas","family":"Naqvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4049-9161","authenticated-orcid":false,"given":"Anannya","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5284-1109","authenticated-orcid":false,"given":"B.","family":"Hareramadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"1","key":"1789_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.fertnstert.2016.05.009","volume":"106","author":"R Azziz","year":"2016","unstructured":"Azziz R. Introduction: determinants of polycystic ovary syndrome. Fertil Steril. 2016;106(1):4\u20135. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.009.","journal-title":"Fertil Steril"},{"key":"1789_CR2","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.3892\/etm.2017.5113","volume":"14","author":"L Chen","year":"2017","unstructured":"Chen L, Hu LM, Wang YF, Yang HY, Huang XY, Zhou W, Sun HX. Genome-wide association study for SNPs associated with PCOS in human patients. Exp Ther Med. 2017;14:4896\u2013900. https:\/\/doi.org\/10.3892\/etm.2017.5113.","journal-title":"Exp Ther Med"},{"issue":"9","key":"1789_CR3","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.3390\/ijms22094905","volume":"22","author":"R Kalyanaraman","year":"2021","unstructured":"Kalyanaraman R, Pal L. A narrative review of current understanding of the pathophysiology of polycystic ovary syndrome: focus on plausible relevance of vitamin D. Int J Mol Sci. 2021;22(9):4905. https:\/\/doi.org\/10.3390\/ijms22094905.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1789_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365. https:\/\/doi.org\/10.1210\/endrev\/bnac001.","journal-title":"Endocr Rev"},{"key":"1789_CR5","unstructured":"World Health Organization. Polycystic ovary syndrome. 2023. Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/polycystic-ovary-syndrome. Accessed 6 Dec 2023."},{"issue":"3","key":"1789_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/2230-8210.131162","volume":"18","author":"B Joshi","year":"2014","unstructured":"Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014;18(3):317\u201324. https:\/\/doi.org\/10.4103\/2230-8210.131162.","journal-title":"Indian J Endocrinol Metab"},{"key":"1789_CR7","doi-asserted-by":"publisher","unstructured":"Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence? Int J Reprod Contracept Obstet Gynecol. 2017;6(11):4971\u2013975. https:\/\/doi.org\/10.18203\/2320-1770.ijrcog20175010.","DOI":"10.18203\/2320-1770.ijrcog20175010"},{"key":"1789_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1530\/EJE-09-1012","volume":"162","author":"MA Ganie","year":"2010","unstructured":"Ganie MA, Marwaha RK, Aggarwal R, Singh S. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur J Endocrinol. 2010;162:1117\u201322. https:\/\/doi.org\/10.1530\/EJE-09-1012.","journal-title":"Eur J Endocrinol"},{"key":"1789_CR9","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.endmts.2021.100085","volume":"3","author":"J Bulsara","year":"2021","unstructured":"Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021;3:100085. https:\/\/doi.org\/10.1016\/j.endmts.2021.100085.","journal-title":"Endocr Metab Sci"},{"issue":"11","key":"1789_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3275\/8108","volume":"34","author":"M Insenser","year":"2011","unstructured":"Insenser M, Escobar-Morreale HF. Application of proteomics to the study of polycystic ovary syndrome. J Endocrinol Invest. 2011;34(11):869\u201375. https:\/\/doi.org\/10.3275\/8108.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1789_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1210\/jc.2014-2086","volume":"100","author":"AS Ambekar","year":"2015","unstructured":"Ambekar AS, Kelkar DS, Pinto SM, Sharma R, Hinduja I, Zaveri K, Pandey A, Prasad TSK, Gowda H, Mukherjee S. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744\u201353. https:\/\/doi.org\/10.1210\/jc.2014-2086.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2021","key":"1789_CR12","doi-asserted-by":"publisher","first-page":"112031","DOI":"10.1016\/j.biopha.2021.112031","volume":"142","author":"CZ Pei","year":"2021","unstructured":"Pei CZ, Jin L, Baek KH. Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics. Biomed Pharmacother. 2021;142(2021):112031. https:\/\/doi.org\/10.1016\/j.biopha.2021.112031.","journal-title":"Biomed Pharmacother"},{"key":"1789_CR13","doi-asserted-by":"publisher","first-page":"11303","DOI":"10.1096\/fj.201802829R","volume":"33","author":"X Li","year":"2019","unstructured":"Li X, Zhu Q, Wang W, Qi J, He Y, Wang Y, He Y, Wang Y, Lu Y, Wu H, Ding Y, Sun Y. Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients. FASEB J. 2019;33:11303\u201313. https:\/\/doi.org\/10.1096\/fj.201802829R.","journal-title":"FASEB J"},{"key":"1789_CR14","doi-asserted-by":"publisher","first-page":"648701","DOI":"10.3389\/fgene.2021.648701","volume":"12","author":"RS Zhao","year":"2021","unstructured":"Zhao RS, Jiang YH, Zhao SG, Zhao H. Multiomics analysis reveals molecular abnormalities in granulosa cells of women with PCOS. Front Genet. 2021;12:648701. https:\/\/doi.org\/10.3389\/fgene.2021.648701.","journal-title":"Front Genet"},{"key":"1789_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s12013-013-9602-z","volume":"67","author":"W Ting","year":"2013","unstructured":"Ting W, Yanyan Q, Jian H. The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome. Cell Biochem Biophys. 2013;67:1041\u20137. https:\/\/doi.org\/10.1007\/s12013-013-9602-z.","journal-title":"Cell Biochem Biophys"},{"issue":"14","key":"1789_CR16","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.3390\/ijms21144853","volume":"21","author":"A Rajska","year":"2020","unstructured":"Rajska A, Buszewska-Forajta M, Racho\u0144 D, Markuszewski MJ. Metabolomic insight into polycystic ovary syndrome- An overview. Int J Mol Sci. 2020;21(14):4853\u201378. https:\/\/doi.org\/10.3390\/ijms21144853.","journal-title":"Int J Mol Sci"},{"key":"1789_CR17","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1210\/jc.2013-2040","volume":"98","author":"A Dunaif","year":"2013","unstructured":"Dunaif A, Fauser B. Renaming PCOS; a two-state solution. J Clin Endocrinol Metab. 2013;98:4325\u20138. https:\/\/doi.org\/10.1210\/jc.2013-2040.","journal-title":"J Clin Endocrinol Metab"},{"key":"1789_CR18","doi-asserted-by":"publisher","unstructured":"Genazzani AD, Genazzani AR. Polycystic ovary syndrome as metabolic disease: new insights on insulin resistance. Touch REV Endocrinol. 2023;19(1):71\u201377. https:\/\/doi.org\/10.17925\/EE.2023.19.1.71.","DOI":"10.17925\/EE.2023.19.1.71"},{"key":"1789_CR19","unstructured":"Sherif K. Metabolic reproductive syndrome\u2019 proposed as new name for PCOS. 2016. Available at https:\/\/www.healio.com\/news\/endocrinology\/20160707\/metabolic-reproductive-syndrome-proposed-as-new-name-for-pcos#:~:text=NEW%20ORLEANS%20\u2014%20Polycystic%20ovary%20syndrome,according%20to%20a%20speaker%20here. Accessed on December 6, 2023."},{"issue":"1","key":"1789_CR20","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1210\/jc.2013-2978","volume":"99","author":"HJ Teede","year":"2014","unstructured":"Teede HJ, Gibson-Helm M, Norman RJ, Boyle J. Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. J Clin Endocrinol Metab. 2014;99(1):E107\u201311. https:\/\/doi.org\/10.1210\/jc.2013-2978.","journal-title":"J Clin Endocrinol Metab"},{"key":"1789_CR21","first-page":"191","volume":"49","author":"M Karoshi","year":"2004","unstructured":"Karoshi M, Okolo SO. Commentary: polycystic ovarian disease (PCOD): a misnomer, looking for a new name. Int J Fertil Women Med. 2004;49:191\u20132.","journal-title":"Int J Fertil Women Med"},{"issue":"2","key":"1789_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13224-016-0851-9","volume":"66","author":"SS Khadilkar","year":"2016","unstructured":"Khadilkar SS. Polycystic ovarian syndrome: is it time to rename PCOS to HA-PODS? J Obst Gynaecol Ind. 2016;66(2):81\u20137. https:\/\/doi.org\/10.1007\/s13224-016-0851-9.","journal-title":"J Obst Gynaecol Ind"},{"key":"1789_CR23","unstructured":"National Institutes of Health. Panel recommends changing name of common disorder in women. 2013. http:\/\/www.nih.gov\/news\/health\/jan2013\/od-23.htm. Accessed on 6 Dec 2023."},{"issue":"1","key":"1789_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13258-010-0150-2","volume":"33","author":"KM Kim","year":"2011","unstructured":"Kim KM, Kang M, Yi EC. Applications of cell-based phage display panning to proteomic analysis. Genes Genom. 2011;33(1):9\u201315. https:\/\/doi.org\/10.1007\/s13258-010-0150-2.","journal-title":"Genes Genom"},{"key":"1789_CR25","doi-asserted-by":"publisher","unstructured":"Martorell-Marug\u00e1n J, L\u00f3pez-Dom\u00ednguez R, Garc\u00eda-Moreno A, Toro-Dom\u00ednguez D, Villatoro-Garc\u00eda JA, Barturen G, Mart\u00edn-G\u00f3mez A, Troule K, G\u00f3mez-L\u00f3pez g, Al-Shahrour F, Gonz\u00e1lez-Rumayor V, Pe\u00f1a-Chilet M, Dopazo J, S\u00e1ez-Rodr\u00edguez j, Marta E, Alarc\u00f3n-Riquelme, Carmona-S\u00e1ez P. A comprehensive database for integrated analysis of omics data in autoimmune diseases. BMC Bioinform. 2021;22(1):343.https:\/\/doi.org\/10.1186\/s12859-021-04268-4.","DOI":"10.1186\/s12859-021-04268-4"},{"key":"1789_CR26","doi-asserted-by":"publisher","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860-921.https:\/\/doi.org\/10.1038\/35057062.","DOI":"10.1038\/35057062"},{"issue":"11","key":"1789_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s100380200092","volume":"47","author":"H Haga","year":"2002","unstructured":"Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. J Hum Genet. 2002;47(11):605\u201310. https:\/\/doi.org\/10.1007\/s100380200092.","journal-title":"J Hum Genet"},{"issue":"1","key":"1789_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/nar\/30.1.158","volume":"30","author":"M Hirakawa","year":"2002","unstructured":"Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res. 2002;30(1):158\u201362. https:\/\/doi.org\/10.1093\/nar\/30.1.158.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1789_CR29","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ng1047","volume":"32","author":"K Ozaki","year":"2002","unstructured":"Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32(4):650\u20134. https:\/\/doi.org\/10.1038\/ng1047.","journal-title":"Nat Genet"},{"issue":"4","key":"1789_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5808\/GI.2012.10.4.220","volume":"10","author":"S Ikegawa","year":"2012","unstructured":"Ikegawa S. A short history of the genome-wide association study: where we were and where we are going. Genomics Inform. 2012;10(4):220\u20135. https:\/\/doi.org\/10.5808\/GI.2012.10.4.220.","journal-title":"Genomics Inform"},{"key":"1789_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2012.10.009","volume":"373","author":"G Kosova","year":"2013","unstructured":"Kosova G, Urbanek M. Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373:29\u201338. https:\/\/doi.org\/10.1016\/j.mce.2012.10.009.","journal-title":"Mol Cell Endocrinol"},{"key":"1789_CR32","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","volume":"6","author":"MG Hayes","year":"2015","unstructured":"Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Dunaif A. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015;6:7502. https:\/\/doi.org\/10.1038\/ncomms8502.","journal-title":"Nat Commun"},{"issue":"12","key":"1789_CR33","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Welt CK. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018;14(12):e1007813. https:\/\/doi.org\/10.1371\/journal.pgen.1007813.","journal-title":"PLoS Genet"},{"issue":"10","key":"1789_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10815-011-9619-4","volume":"28","author":"E Dolfin","year":"2011","unstructured":"Dolfin E, Guani B, Lussiana C, Mari C, Restagno G, Revelli A. FSH-receptor ALA307THR polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women. J Assist Reprod Genet. 2011;28(10):925\u201330. https:\/\/doi.org\/10.1007\/s10815-011-9619-4.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"1789_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","volume":"26","author":"JM McAllister","year":"2015","unstructured":"McAllister JM, Legro RS, Modi BP, Strauss JF. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab. 2015;26(3):118\u201324. https:\/\/doi.org\/10.1016\/j.tem.2014.12.004.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1789_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/jog.13250","volume":"43","author":"GV Reis","year":"2017","unstructured":"Reis GV, Gontijo NA, Rodrigues KF, Alves MT, Ferreira CN, Gomes KB. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: a systematic review. J Obstet Gynaecol Res. 2017;43(3):436\u201346. https:\/\/doi.org\/10.1111\/jog.13250.","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"1789_CR37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J, Chen ZJ. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020\u20137. https:\/\/doi.org\/10.1038\/ng.2384.","journal-title":"Nat Genet"},{"issue":"2","key":"1789_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/09513590.2017.1371128","volume":"34","author":"S Siddamalla","year":"2018","unstructured":"Siddamalla S, Reddy TV, Govatati S, Erram N, Deenadayal M, Shivaji S, Bhanoori M. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in south Indian women. Gynecol Endocrinol. 2018;34(2):161\u20135. https:\/\/doi.org\/10.1080\/09513590.2017.1371128.","journal-title":"Gynecol Endocrinol"},{"key":"1789_CR39","doi-asserted-by":"publisher","unstructured":"Lathief S, Pal L. Chapter 19: emerging concepts: role of vitamin d deficiency in the pathogenesis of PCOS. In: Pal L, editor. Polycystic ovary syndrome: current and emerging concepts. \u00a9Springer Science & Business Media New York; 2014. Pp 317\u2013331. https:\/\/doi.org\/10.1007\/978-1-4614-8394-6_19.","DOI":"10.1007\/978-1-4614-8394-6_19"},{"issue":"2018","key":"1789_CR40","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3389\/fphys.2018.01902","volume":"9","author":"YM Niu","year":"2018","unstructured":"Niu YM, Wang YD, Jiang GB, Bai G, Chai HB, Li XF, Hu YY, Shen M. Association between vitamin D receptor gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis. Front Physiol. 2018;9(2018):1902. https:\/\/doi.org\/10.3389\/fphys.2018.01902.","journal-title":"Front Physiol"},{"issue":"2","key":"1789_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/09513590.2018.1512966","volume":"35","author":"LB Xavier","year":"2019","unstructured":"Xavier LB, Gontijo NA, Rodrigues KF, Candido AL, Dos Reis FM, de Sousa M, Silveira JN, Oliveira Silva IF, Ferreira CN, Gomes KB. Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women. Gynecol Endocrinol. 2019;35(2):146\u20139. https:\/\/doi.org\/10.1080\/09513590.2018.1512966.","journal-title":"Gynecol Endocrinol"},{"issue":"2018","key":"1789_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcte.2018.05.002","volume":"13","author":"A Giandalia","year":"2018","unstructured":"Giandalia A, Pappalardo MA, Russo GT, Romeo EL, Alibrandi A, Di Bari F, Vita R, Cucinotta D, Benvenga S. Influence of peroxisome proliferator-activated receptor-gamma exon 2 and exon 6 and insulin receptor substrate (IRS)-1 gly972arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome. J Clin Transl Endocrinol. 2018;13(2018):1\u20138. https:\/\/doi.org\/10.1016\/j.jcte.2018.05.002.","journal-title":"J Clin Transl Endocrinol"},{"key":"1789_CR43","doi-asserted-by":"publisher","unstructured":"Rahimi Z, Chamaie-Nejad F, Saeidi S, Rahimi Z, Ebrahimi A, Shakiba E, Vaisi-Raygani A. The association of ppargamma pro12ala and c161t polymorphisms with polycystic ovary syndrome and their influence on lipid and lipoprotein profiles. Int J Fertil Steril. 2018;12(2):147\u201351. https:\/\/doi.org\/10.22074\/ijfs.2018.5270.","DOI":"10.22074\/ijfs.2018.5270"},{"key":"1789_CR44","doi-asserted-by":"publisher","first-page":"6130487","DOI":"10.1155\/2018\/6130487","volume":"2018","author":"B \u0160enk","year":"2018","unstructured":"\u0160enk B, Gori\u010dar K, Kravos NA, Jensterle Sever M, Jane\u017e A, Dol\u017ean V. SLC6A45HTTLPR polymorphism affects insulin secretion in patients with polycystic ovary syndrome. Int J Endocrinol. 2018;2018:6130487. https:\/\/doi.org\/10.1155\/2018\/6130487.","journal-title":"Int J Endocrinol"},{"key":"1789_CR45","doi-asserted-by":"publisher","first-page":"6076274","DOI":"10.1155\/2020\/6076274","volume":"2020","author":"AF Alkhuriji","year":"2020","unstructured":"Alkhuriji AF, Al Omar SY, Babay ZA, El-Khadragy MF, Mansour LA, Alharbi WG, Khalil MI. Association of IL-1\u03b2, IL-6, TNF-\u03b1, and TGF\u03b21 gene polymorphisms with recurrent spontaneous abortion in polycystic ovary syndrome. Dis Markers. 2020;2020:6076274. https:\/\/doi.org\/10.1155\/2020\/6076274.","journal-title":"Dis Markers"},{"issue":"2020","key":"1789_CR46","doi-asserted-by":"publisher","first-page":"103134","DOI":"10.1016\/j.jri.2020.103134","volume":"140","author":"JJ Benjamin","year":"2020","unstructured":"Benjamin JJ, Koshy T, Kumar KM, Maruthy KN, Padmavathi R. Meta-analysis of association between il-6-174 g\/c polymorphism and female infertility related disorders. J Reprod Immunol. 2020;140(2020):103134. https:\/\/doi.org\/10.1016\/j.jri.2020.103134.","journal-title":"J Reprod Immunol"},{"issue":"10","key":"1789_CR47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.5603\/GP.a2020.0176","volume":"92","author":"F Beyazit","year":"2021","unstructured":"Beyazit F, Hiz MM, Turkon H, Unsal MA. Serum spexin, adiponectin and leptin levels in polycystic ovarian syndrome in association with FTO gene polymorphism. Ginekol Pol. 2021;92(10):682\u20138. https:\/\/doi.org\/10.5603\/GP.a2020.0176.","journal-title":"Ginekol Pol"},{"key":"1789_CR48","doi-asserted-by":"publisher","unstructured":"Gulbay G, Yesilada E, Celik O, Yologlu S. The investigation of polymorphisms in DNA repair genes (xrcc1, ape1 and xpd) in women with polycystic ovary syndrome. Asian Pac J Cancer Prev. 2017;18(5):1219\u201323. https:\/\/doi.org\/10.22034\/APJCP.2017.18.5.1219.","DOI":"10.22034\/APJCP.2017.18.5.1219"},{"issue":"11","key":"1789_CR49","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1080\/09513590.2019.1616689","volume":"35","author":"E Asanidze","year":"2019","unstructured":"Asanidze E, Kristesashvili J, Pkhaladze L, Khomasuridze A. The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents. Gynecol Endocrinol. 2019;35(11):974\u20137. https:\/\/doi.org\/10.1080\/09513590.2019.1616689.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1789_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13048-020-00699-4","volume":"13","author":"D Chen","year":"2020","unstructured":"Chen D, Zhu X, Wu J. Can polymorphisms of AMH\/AMHR2 affect ovarian stimulation outcomes? A systematic review and meta-analysis. J Ovarian Res. 2020;13(1):103. https:\/\/doi.org\/10.1186\/s13048-020-00699-4.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1789_CR51","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/19396368.2019.1595217","volume":"65","author":"R Deswal","year":"2019","unstructured":"Deswal R, Nanda S, Dang AS. Association of luteinizing hormone and lh receptor gene polymorphism with susceptibility of polycystic ovary syndrome. Syst Biol Reprod Med. 2019;65(5):400\u20138. https:\/\/doi.org\/10.1080\/19396368.2019.1595217.","journal-title":"Syst Biol Reprod Med"},{"issue":"1","key":"1789_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/09513590.2018.1498834","volume":"35","author":"J Zou","year":"2019","unstructured":"Zou J, Wu D, Liu Y, Tan S. Association of luteinizing hormone\/ choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk: a meta-analysis. Gynecol Endocrinol. 2019;35(1):81\u20135. https:\/\/doi.org\/10.1080\/09513590.2018.1498834.","journal-title":"Gynecol Endocrinol"},{"key":"1789_CR53","doi-asserted-by":"publisher","unstructured":"Kim JJ, Choi YM, Hong MA, Chae SJ, Hwang K, Yoon SH, Ku SY, Suh CS, Kim SH. FSH receptor gene p. Thr307ala and p. Asn680ser polymorphisms are associated with the risk of polycystic ovary syndrome J Assist Reprod Genet. 2017;34(8):1087\u201393. https:\/\/doi.org\/10.1007\/s10815-017-0953-z.","DOI":"10.1007\/s10815-017-0953-z"},{"key":"1789_CR54","doi-asserted-by":"publisher","first-page":"49109","DOI":"10.1155\/2007\/49109","volume":"2007","author":"U Unluturk","year":"2007","unstructured":"Unluturk U, Harmanci A, Kocaefe C, Yildiz BO. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-\u03b3. PPAR Res. 2007;2007:49109. https:\/\/doi.org\/10.1155\/2007\/49109.","journal-title":"PPAR Res"},{"issue":"12","key":"1789_CR55","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1210\/me.2004-0074","volume":"18","author":"E Jansen","year":"2004","unstructured":"Jansen E, Laven JSE, Dommerholt HBR, Polman J, van Rijt C, van den Hurk C, Westland J, Mosselman S, Fauser BCJM. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol. 2004;18(12):3050\u201363. https:\/\/doi.org\/10.1210\/me.2004-0074.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"1789_CR56","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1210\/jc.2015-4275","volume":"101","author":"J Adams","year":"2016","unstructured":"Adams J, Liu Z, Ren YA, Wun WS, Zhou W, Kenigsberg S, Librach C, Valdes C, Gibbons W, Richards J. Enhanced inflammatory transcriptome in the granulosa cells of women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2016;101(9):3459\u201368. https:\/\/doi.org\/10.1210\/jc.2015-4275.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1789_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2144\/04371RR03","volume":"37","author":"K Dheda","year":"2004","unstructured":"Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques. 2004;37(1):112\u20134. https:\/\/doi.org\/10.2144\/04371RR03.","journal-title":"Biotechniques"},{"issue":"39","key":"1789_CR58","doi-asserted-by":"publisher","first-page":"24213","DOI":"10.1073\/pnas.2008323117","volume":"117","author":"H Geekiyanage","year":"2020","unstructured":"Geekiyanage H, Rayatpisheh S, Wohlschlegel JA, Brown R Jr, Ambros V. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. PNAS. 2020;117(39):24213\u201323. https:\/\/doi.org\/10.1073\/pnas.2008323117.","journal-title":"PNAS"},{"issue":"2","key":"1789_CR59","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","volume":"171","author":"W Ying","year":"2017","unstructured":"Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A, Fu W, Li P, Olefsky JM. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell. 2017;171(2):372-384.e12. https:\/\/doi.org\/10.1016\/j.cell.2017.08.035.","journal-title":"Cell"},{"key":"1789_CR60","doi-asserted-by":"publisher","first-page":"110478","DOI":"10.1016\/j.mce.2019.110478","volume":"494","author":"Y Song","year":"2019","unstructured":"Song Y, Yu G, Xiang Y, Li Y, Wan L, Tan L. Altered mir-186 and mir-135a contribute to granulosa cell dysfunction by targeting esr2: a possible role in polycystic ovary syndrome. Mol Cell Endocrinol. 2019;494:110478. https:\/\/doi.org\/10.1016\/j.mce.2019.110478.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"1789_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/molehr\/gaaa044","volume":"26","author":"L Jiang","year":"2020","unstructured":"Jiang L, Huang H, Qian Y, Li Y, Chen X, Di N, Yang D. MiR-130b regulates gap junctional intercellular communication through connexin 43 in granulosa cells from patients with polycystic ovary syndrome. Mol Hum Reprod. 2020;26(8):576\u201384. https:\/\/doi.org\/10.1093\/molehr\/gaaa044.","journal-title":"Mol Hum Reprod"},{"key":"1789_CR62","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.preghy.2019.03.012","volume":"16","author":"ML Martinez-Fierro","year":"2019","unstructured":"Martinez-Fierro ML, Carrillo-Arriaga JG, Luevano M, Lugo-Trampe A, Delgado-Enciso I, Rodriguez-Sanchez IP, Garza-Veloz I. Serum levels of miR-628-3p and miR-628-5p during the early pregnancy are increased in women who subsequently develop preeclampsia. Pregnancy Hypertens. 2019;16:120\u20135. https:\/\/doi.org\/10.1016\/j.preghy.2019.03.012.","journal-title":"Pregnancy Hypertens"},{"key":"1789_CR63","doi-asserted-by":"publisher","first-page":"e206974","DOI":"10.1371\/journal.pone.0206974","volume":"13","author":"W Gallo","year":"2018","unstructured":"Gallo W, Esguerra J, Eliasson L, Melander O. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease. PLoS One. 2018;13:e206974. https:\/\/doi.org\/10.1371\/journal.pone.0206974.","journal-title":"PLoS One"},{"key":"1789_CR64","doi-asserted-by":"publisher","first-page":"e143812","DOI":"10.1172\/jci.insight.143812","volume":"5","author":"J Dong","year":"2020","unstructured":"Dong J, He M, Li J, Pessentheiner A, Wang C, Zhang J, Sun Y, Wang WT, Zhang Y, Liu J, Wang SC, Huang PH, Gordts PL, Yuan ZY, Tsimikas S, Shyy JY. microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production. JCI Insight. 2020;5:e143812. https:\/\/doi.org\/10.1172\/jci.insight.143812.","journal-title":"JCI Insight"},{"issue":"8","key":"1789_CR65","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/09513590.2018.1540567","volume":"35","author":"X Li","year":"2019","unstructured":"Li X, Qi J, Zhu Q, He Y, Wang Y, Lu Y, Wu H, Sun Y. The role of androgen in autophagy of granulosa cells from pcos. Gynecol Endocrinol. 2019;35(8):669\u201372. https:\/\/doi.org\/10.1080\/09513590.2018.1540567.","journal-title":"Gynecol Endocrinol"},{"key":"1789_CR66","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1789_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.reprotox.2022.04.010","volume":"111","author":"YN Liu","year":"2022","unstructured":"Liu YN, Qin Yi WuB, Peng H, Li M, Luo H, Liu LL. DNA methylation in polycystic ovary syndrome: emerging evidence and challenges. Reprod Toxicol. 2022;111:11\u20139. https:\/\/doi.org\/10.1016\/j.reprotox.2022.04.010.","journal-title":"Reprod Toxicol"},{"issue":"5","key":"1789_CR68","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.ygeno.2020.04.011","volume":"112","author":"HL Zhu","year":"2020","unstructured":"Zhu HL, Chen YQ, Zhang ZF. Downregulation of lncRNAzfas1 and upregulation of microRNA-129 repress endocrine disturbance, increase proliferation and inhibit apoptosis of ovarian granulosa cells in polycystic ovarian syndrome by downregulating HMGB1. Genomics. 2020;112(5):3597\u2013608. https:\/\/doi.org\/10.1016\/j.ygeno.2020.04.011.","journal-title":"Genomics"},{"issue":"1","key":"1789_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13048-020-00742-4","volume":"14","author":"H Guo","year":"2021","unstructured":"Guo H, Li T, Sun X. Lnc-RNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS. J Ovarian Res. 2021;14(1):19. https:\/\/doi.org\/10.1186\/s13048-020-00742-4.","journal-title":"J Ovarian Res"},{"key":"1789_CR70","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.fertnstert.2015.04.005","volume":"104","author":"YY Yu","year":"2015","unstructured":"Yu YY, Sun CX, Liu YK, Li Y, Wang L, Zhang W. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome. Fertil Steril. 2015;104:145\u201353. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.04.005.","journal-title":"Fertil Steril"},{"key":"1789_CR71","doi-asserted-by":"publisher","unstructured":"Xu J, Bao X, Peng Z, Wang L, Du L, Niu W, Sun Y. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell. Oncotarget. 2016;7:27899\u2013909. https:\/\/doi.org\/10.18632\/oncotarget.8544.","DOI":"10.18632\/oncotarget.8544"},{"issue":"8","key":"1789_CR72","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1021\/acs.jproteome.0c00186","volume":"9","author":"S Guan","year":"2020","unstructured":"Guan S, Taylor PP, Han Z, Moran MF, Ma B. Data Dependent-Independent Acquisition (DDIA) proteomics. J Proteome Res. 2020;9(8):3230\u20137. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00186.","journal-title":"J Proteome Res"},{"key":"1789_CR73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12920-021-00962-7","volume":"14","author":"Y Yu","year":"2021","unstructured":"Yu Y, Tan P, Zhuang Z, Wang Z, Zhu L, Qiu R, Xu H. DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS. BMC Med Genomics. 2021;14:125. https:\/\/doi.org\/10.1186\/s12920-021-00962-7.","journal-title":"BMC Med Genomics"},{"key":"1789_CR74","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12920-021-01058-y","volume":"14","author":"Y Yu","year":"2021","unstructured":"Yu Y, Tan P, Zhuang Z, Wang Z, Zhu L, Qiu R, Xu H. Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome. BMC Med Genomics. 2021;14:206. https:\/\/doi.org\/10.1186\/s12920-021-01058-y.","journal-title":"BMC Med Genomics"},{"issue":"8","key":"1789_CR75","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s00125-006-0317-1","volume":"49","author":"A Kretowski","year":"2006","unstructured":"Kretowski A, Hokanson JE, McFann K, Kinney GL, Snell-Bergeon JK, Maahs DM, Wadwa RP, Eckel RH, Ogden LG, Garg SK, Li J, Cheng S, Erlich HA, Rewers M. The apolipoprotein A-IV GLN360HIS polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes. Diabetologia. 2006;49(8):1946\u201354. https:\/\/doi.org\/10.1007\/s00125-006-0317-1.","journal-title":"Diabetologia"},{"issue":"1","key":"1789_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-019-0846-9","volume":"18","author":"E Gourgari","year":"2019","unstructured":"Gourgari E, Ma J, Playford MP, Mehta NN, Goldman R, Remaley RT, Gordon M. Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study. Cardiovasc Diabetol. 2019;18(1):43. https:\/\/doi.org\/10.1186\/s12933-019-0846-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1789_CR77","doi-asserted-by":"publisher","first-page":"0214742","DOI":"10.1371\/journal.pone.0214742","volume":"14","author":"K Patil","year":"2019","unstructured":"Patil K, Yelamanchi S, Kumar M, Hinduja I, Prasad T, Gowda H, Mukherjee S. Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome. PLoS One. 2019;14(4):0214742. https:\/\/doi.org\/10.1371\/journal.pone.0214742.","journal-title":"PLoS One"},{"issue":"5","key":"1789_CR78","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3892\/ijmm.2020.4522","volume":"45","author":"L Li","year":"2020","unstructured":"Li L, Zhang J, Zeng J, Liao B, Peng X, Li T, Li J, Tan Q, Li X, Yang Y, Chen Z, Liang Z. Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome. Int J Mol Med. 2020;45(5):1409\u201316. https:\/\/doi.org\/10.3892\/ijmm.2020.4522.","journal-title":"Int J Mol Med"},{"issue":"5","key":"1789_CR79","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/nu13051677","volume":"13","author":"M Iervolino","year":"2021","unstructured":"Iervolino M, Lepore E, Forte G, Lagan AS, Buzzaccarini G, Unfer V. Natural molecules in the management of polycystic ovary syndrome (PCOS): an analytical review. Nutrients. 2021;13(5):1677. https:\/\/doi.org\/10.3390\/nu13051677.","journal-title":"Nutrients"},{"issue":"2021","key":"1789_CR80","doi-asserted-by":"publisher","first-page":"667422","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"B Liao","year":"2021","unstructured":"Liao B, Qiao J, Pang Y. Central regulation of PCOS: Abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front Endocrinol. 2021;12(2021):667422. https:\/\/doi.org\/10.3389\/fendo.2021.667422.","journal-title":"Front Endocrinol"},{"issue":"12","key":"1789_CR81","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1093\/humrep\/dez214","volume":"34","author":"N Dilaver","year":"2019","unstructured":"Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, Mason HD, Rice H. The regulation and signaling of anti-Mullerian hormone in human granulosa cells: relevance to polycystic ovary syndrome. Hum Reprod. 2019;34(12):2467\u201379. https:\/\/doi.org\/10.1093\/humrep\/dez214.","journal-title":"Hum Reprod"},{"issue":"4","key":"1789_CR82","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/09513590.2019.1653844","volume":"36","author":"X Qiu","year":"2020","unstructured":"Qiu X, Wei Y, Liu C, Ding C, Zhao S. Hyperandrogen enhances apoptosis of human ovarian granulosa cells via up-regulation and demethylation of PDCD4. Gynecol Endocrinol. 2020;36(4):333\u20137. https:\/\/doi.org\/10.1080\/09513590.2019.1653844.","journal-title":"Gynecol Endocrinol"},{"key":"1789_CR83","doi-asserted-by":"publisher","unstructured":"Kunitomi C, Harada M, Kusamoto A, Azhary JM, Nose E, Koike H, Xu Z, Urata Y, Takahashi N, Wada-Hiraike O, Hirota Y, Koga K, Fujii T, Osuga Y. Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome. Mol Hum Reprod. 2021;27(3). https:\/\/doi.org\/10.1093\/molehr\/gaab003.","DOI":"10.1093\/molehr\/gaab003"},{"issue":"1","key":"1789_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jgyn.2015.08.013","volume":"46","author":"XQ Wu","year":"2017","unstructured":"Wu XQ, Wang YQ, Xu SM, Liu JF, Bi XY, Wang ZQ, Zhang JP. The WNT\/ beta-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in north China. J Gynecol Obstet Hum Reprod. 2017;46(1):93\u20139. https:\/\/doi.org\/10.1016\/j.jgyn.2015.08.013.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"6","key":"1789_CR85","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.fertnstert.2014.02.040","volume":"101","author":"AM Sanchez","year":"2014","unstructured":"Sanchez AM, Vigano P, Quattrone F, Pagliardini L, Papaleo E, Candiani M, Panina-Bordignon P. The WNT\/beta-catenin signaling pathway and expression of survival promoting genes in luteinized granulosa cells: Endometriosis as a paradigm for a dysregulated apoptosis pathway. Fertil Steril. 2014;101(6):1688\u201396. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.040.","journal-title":"Fertil Steril"},{"issue":"10","key":"1789_CR86","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s10815-018-1235-0","volume":"35","author":"K Maas","year":"2018","unstructured":"Maas K, Mirabal S, Penzias A, Sweetnam PM, Eggan KC, Sakkas D. Hippo signaling in the ovary and polycystic ovarian syndrome. J Assist Reprod Genet. 2018;35(10):1763\u201371. https:\/\/doi.org\/10.1007\/s10815-018-1235-0.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"1789_CR87","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y. Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci. 2017;24(5):646\u201355. https:\/\/doi.org\/10.1177\/1933719116667606.","journal-title":"Reprod Sci"},{"issue":"1","key":"1789_CR88","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-020-00677-x","volume":"18","author":"Y Gong","year":"2020","unstructured":"Gong Y, Luo S, Fan P, Zhu H, Li Y, Huang W. Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2020;18(1):121. https:\/\/doi.org\/10.1186\/s12958-020-00677-x.","journal-title":"Reprod Biol Endocrinol"},{"key":"1789_CR89","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.omtn.2020.11.005","volume":"23","author":"L Bai","year":"2021","unstructured":"Bai L, Wang WY, Xiang S, Wang S, Wan S, Zhu Y. Aberrant elevation of GDF8 impairs granulosa cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS. Mol Ther Nucleic Acids. 2021;23:294\u2013309. https:\/\/doi.org\/10.1016\/j.omtn.2020.11.005.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"1789_CR90","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/metabo11120869","volume":"11","author":"W Chen","year":"2021","unstructured":"Chen W, Pang Y. Metabolic Syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. 2021;11(12):869. https:\/\/doi.org\/10.3390\/metabo11120869.","journal-title":"Metabolites"},{"key":"1789_CR91","doi-asserted-by":"publisher","first-page":"25435","DOI":"10.1074\/jbc.R111.238691","volume":"286","author":"Z Lei","year":"2011","unstructured":"Lei Z, Huhman DV, Sumner LW. Mass spectrometry strategies in metabolomics. J Biol Chem. 2011;286:25435\u201342. https:\/\/doi.org\/10.1074\/jbc.R111.238691.","journal-title":"J Biol Chem"},{"key":"1789_CR92","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2013.12.018","volume":"429","author":"M Murri","year":"2014","unstructured":"Murri M, Insenser M, Escobar-Morreale HF. Metabolomics in polycystic ovary syndrome. Clin Chim Acta. 2014;429:181\u20138. https:\/\/doi.org\/10.1016\/j.cca.2013.12.018.","journal-title":"Clin Chim Acta"},{"key":"1789_CR93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","volume":"43","author":"AS Edison","year":"2017","unstructured":"Edison AS, Markley JL, Bru R, Eghbalnia HR, Powers R, Raftery D, Wishart DS. The future of NMR-based metabolomics. Curr Opin Biotechnol. 2017;43:34\u201340. https:\/\/doi.org\/10.1016\/j.copbio.2016.08.001.","journal-title":"Curr Opin Biotechnol"},{"key":"1789_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnmrs.2017.01.001","volume":"100","author":"DD Marshall","year":"2017","unstructured":"Marshall DD, Powers R. Beyond the paradigm: combining mass spectrometry and nuclear magnetic resonance for metabolomics. Prog Nucl Magn Reson Spectrosc. 2017;100:1\u201316. https:\/\/doi.org\/10.1016\/j.pnmrs.2017.01.001.","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"1789_CR95","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1021\/acs.analchem.9b04618","volume":"92","author":"S Guo","year":"2020","unstructured":"Guo S, Tang W, Hu Y, Chen Y, Gordon A, Li B, Li P. Enhancement of on-tissue chemical derivatization by laser-assisted tissue transfer for MALDI MS imaging. Anal Chem. 2020;92:1431\u20138. https:\/\/doi.org\/10.1021\/acs.analchem.9b04618.","journal-title":"Anal Chem"},{"issue":"03\/04","key":"1789_CR96","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0041-1729841","volume":"39","author":"S Alesi","year":"2021","unstructured":"Alesi S, Ghelani D, Mousa A. Metabolomic biomarkers in polycystic ovary syndrome: a review of the evidence. Semin Reprod Med. 2021;39(03\/04):102\u201310. https:\/\/doi.org\/10.1055\/s-0041-1729841.","journal-title":"Semin Reprod Med"},{"issue":"3","key":"1789_CR97","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2478\/rrlm-2020-0017","volume":"28","author":"CL Vonica","year":"2020","unstructured":"Vonica CL, Farcas AD, Roman G, Muresan AA, Fodor A, Cernea S, Georgescu CE. Metabolomic biomarkers of polycystic ovary syndrome related-obesity: a review of the literature. Rev Rom Med Lab (Rom J Lab Med). 2020;28(3):241\u201355. https:\/\/doi.org\/10.2478\/rrlm-2020-0017.","journal-title":"Rev Rom Med Lab (Rom J Lab Med)"},{"issue":"5","key":"1789_CR98","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1021\/pr3000317","volume":"11","author":"L Sun","year":"2012","unstructured":"Sun L, Hu W, Liu Q, Hao Q, Sun B, Zhang Q, Mao S, Qiao J, Yan X. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 2012;11(5):2937\u201346. https:\/\/doi.org\/10.1021\/pr3000317.","journal-title":"J Proteome Res"},{"key":"1789_CR99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","volume":"17","author":"Z Sun","year":"2019","unstructured":"Sun Z, Chang HM, Wang A, Song J, Zhang X, Guo J, Leung PCK, Lian F. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reprod Biol Endocrinol. 2019;17:45. https:\/\/doi.org\/10.1186\/s12958-019-0490-y.","journal-title":"Reprod Biol Endocrinol"},{"key":"1789_CR100","doi-asserted-by":"publisher","first-page":"437442","DOI":"10.1080\/00365513.1658215","volume":"79","author":"CL Vonica","year":"2019","unstructured":"Vonica CL, Ilie IR, Socaciu C, Moraru C, Georgescu B, Farca\u015f A, Roman G, Mure\u015fan AA, Georgescu CE. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography\u2013quadrupole time of flight electrospray in a positive ionization mode mass spectrometry. Scand J Clin Lab Investig. 2019;79:437442. https:\/\/doi.org\/10.1080\/00365513.1658215.","journal-title":"Scand J Clin Lab Investig"},{"issue":"1","key":"1789_CR101","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ando.2022.07.675","volume":"84","author":"IRP Ilie","year":"2023","unstructured":"Ilie IRP, Herdean AM, Ioan Herdean AI, Georgescu CE. Lipidomic biomarkers in polycystic ovary syndrome: an overview. Ann Endocrinol. 2023;84(1):69\u201380. https:\/\/doi.org\/10.1016\/j.ando.2022.07.675.","journal-title":"Ann Endocrinol"},{"key":"1789_CR102","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/molehr\/gas029","volume":"18","author":"W Atiomo","year":"2012","unstructured":"Atiomo W, Daykin CA. Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study. Mol Hum Reprod. 2012;18:546\u201353. https:\/\/doi.org\/10.1093\/molehr\/gas029.","journal-title":"Mol Hum Reprod"},{"key":"1789_CR103","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","volume":"58","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, Samino S, Insenser M, Vinaixa M, Luque-Ram\u00edrez M, Lasunci\u00f3n MA, Correig X. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC\u2013MS. Clin Chem. 2012;58:999\u20131009. https:\/\/doi.org\/10.1373\/clinchem.2011.176396.","journal-title":"Clin Chem"},{"key":"1789_CR104","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19:268\u201388. https:\/\/doi.org\/10.1093\/humupd\/dms059.","journal-title":"Hum Reprod Update"},{"key":"1789_CR105","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jsbmb.2018.10.012","volume":"186","author":"M Buszewska-Forajta","year":"2019","unstructured":"Buszewska-Forajta M, Rachon D, Stefaniak A, Wawrzyniak R, Konieczna A, Kowalewska A, Markuszewski MJ. Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique. J Steroid Biochem Mol Biol. 2019;186:176\u201384. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.10.012.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1789_CR106","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with Polycystic Ovarian Syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:9240569. https:\/\/doi.org\/10.1155\/2022\/9240569.","journal-title":"J Healthc Eng"},{"key":"1789_CR107","unstructured":"Barbieri RL (2023) Steroid hormone metabolism in polycystic ovary syndrome. https:\/\/www.uptodate.com\/contents\/steroid-hormone-metabolism-in-polycystic-ovary-syndrome.\u00a0Accessed 6 Dec 2023."},{"issue":"4","key":"1789_CR108","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.rbmo.2021.11.012","volume":"44","author":"Z Ye","year":"2022","unstructured":"Ye Z, Zhang C, Wang S, Zhang Y, Li R, Zhao Y, Qiao J. Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances. Reprod Biomed Online. 2022;44(4):737\u201346. https:\/\/doi.org\/10.1016\/j.rbmo.2021.11.012.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"1789_CR109","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000323874","volume":"29","author":"JP Hamilton","year":"2011","unstructured":"Hamilton JP. Epigenetics: principles and practice. Dig Dis. 2011;29(2):130\u20135. https:\/\/doi.org\/10.1159\/000323874.","journal-title":"Dig Dis"},{"key":"1789_CR110","doi-asserted-by":"publisher","unstructured":"Medvedeva YA, Lennartsson A, Ehsani R, Kulakovskiy IV, Vorontsov IE, Panahandeh P, Khimulya G, Kasukawa T,\u00a0The FANTOM Consortium,\u00a0Drabl\u00f8s F. EpiFactors: a comprehensive database of human epigenetic factors and complexes. Database. 2015;2015:bav067. https:\/\/doi.org\/10.1093\/database\/bav067.","DOI":"10.1093\/database\/bav067"},{"issue":"6","key":"1789_CR111","doi-asserted-by":"publisher","first-page":"D564","DOI":"10.1093\/nar\/gkac989","volume":"51","author":"D Marakulina","year":"2022","unstructured":"Marakulina D, Vorontsov IE, Kulakovskiy IV, Lennartsson A, Drabl\u00f8s F, Medvedeva YA. EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes. Nucl Acid Res. 2022;51(6):D564\u201370. https:\/\/doi.org\/10.1093\/nar\/gkac989.","journal-title":"Nucl Acid Res"},{"key":"1789_CR112","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fgene.2018.00640","volume":"9","author":"S Kumar","year":"2018","unstructured":"Kumar S, Chinnusamy V, Mohapatra T. Epigenetics of modified DNA Bases: 5-Methylcytosine and beyond. Front Genet. 2018;9:640. https:\/\/doi.org\/10.3389\/fgene.2018.00640.","journal-title":"Front Genet"},{"issue":"3","key":"1789_CR113","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s43032-021-00516-3","volume":"29","author":"MC Eiras","year":"2022","unstructured":"Eiras MC, Pinheiro DP, Romcy KAM, Ferriani RA, Reis RMD, Furtado CLM. Polycystic ovary syndrome: the epigenetics behind the disease. Reprod Sci. 2022;29(3):680\u201394. https:\/\/doi.org\/10.1007\/s43032-021-00516-3.","journal-title":"Reprod Sci"},{"issue":"1","key":"1789_CR114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/GRF.0000000000000581","volume":"64","author":"JC Combs","year":"2021","unstructured":"Combs JC, Hill MJ, Decherney AH. Polycystic ovarian syndrome genetics and epigenetics. Clin Obstet Gynecol. 2021;64(1):20\u20135. https:\/\/doi.org\/10.1097\/GRF.0000000000000581.","journal-title":"Clin Obstet Gynecol"},{"issue":"10","key":"1789_CR115","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4161\/15592294.2014.969617","volume":"9","author":"GM Martin-Nunez","year":"2014","unstructured":"Martin-Nunez GM, Rubio-Martin E, Cabrera-Mulero R, Rojo-Martinez Olveira G, Valdes S, Soriguer F, Castano L, Morcillo S. Type 2 diabetes mellitus in relation to global LINE-1 DNA methylation in peripheral blood: a cohort study. Epigenet. 2014;9(10):1322\u20138. https:\/\/doi.org\/10.4161\/15592294.2014.969617.","journal-title":"Epigenet"},{"issue":"11","key":"1789_CR116","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1007\/s43032-021-00589-0","volume":"28","author":"D Oliveira","year":"2021","unstructured":"Oliveira D, Hentze J, O\u2019Rourke CJ, Andersen JB, Hogdall C, Hogdall EV. DNA methylation in ovarian tumors- a comparison between fresh tissue and FFPE samples. Reprod Sci. 2021;28(11):3212\u20138. https:\/\/doi.org\/10.1007\/s43032-021-00589-0.","journal-title":"Reprod Sci"},{"key":"1789_CR117","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/THC-218002","volume":"29","author":"X Zhong","year":"2021","unstructured":"Zhong X, Jin F, Huang C, Du M, Gao M, Wei X. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS). Technol Health Care. 2021;29:S11\u201325. https:\/\/doi.org\/10.3233\/THC-218002.","journal-title":"Technol Health Care"},{"key":"1789_CR118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.reprotox.2022.04.010","volume":"111","author":"YN Liu","year":"2022","unstructured":"Liu YN, Qin Yi WuB, Peng H, Li M, Luo H, Liu LL. DNA methylation in polycystic ovary syndrome: emerging evidence and challenges. Reprod Toxicol. 2022;111:11\u20139. https:\/\/doi.org\/10.1016\/j.reprotox.2022.04.010.","journal-title":"Reprod Toxicol"},{"key":"1789_CR119","doi-asserted-by":"publisher","unstructured":"Wang XX, Wei JZ, Jiao J, Jiang SY, Yu DH, Li D. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget. 2014;5(16):6603\u20136610. https:\/\/doi.org\/10.18632\/oncotarget.2224.","DOI":"10.18632\/oncotarget.2224"},{"key":"1789_CR120","doi-asserted-by":"publisher","first-page":"16890","DOI":"10.1038\/srep16890","volume":"5","author":"T Sathyapalan","year":"2015","unstructured":"Sathyapalan T, David R, Gooderham NJ, Atkin SL. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep. 2015;5:16890. https:\/\/doi.org\/10.1038\/srep16890.","journal-title":"Sci Rep"},{"issue":"1","key":"1789_CR121","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/REP-18-0449","volume":"158","author":"ER V\u00e1zquez-Mart\u00ednez","year":"2019","unstructured":"V\u00e1zquez-Mart\u00ednez ER, G\u00f3mez-Viais YI, Garc\u00eda-G\u00f3mez E, Reyes-Mayoral C, Reyes-Mu\u00f1oz E, Camacho-Arroyo I, Cerb\u00f3n M. DNA methylation in the pathogenesis of polycystic ovary syndrome. Reproduction (Cambridge, England). 2019;158(1):R27\u201340. https:\/\/doi.org\/10.1530\/REP-18-0449.","journal-title":"Reproduction (Cambridge, England)"},{"key":"1789_CR122","doi-asserted-by":"publisher","first-page":"110611","DOI":"10.1016\/j.mce.2019.110611","volume":"500","author":"E Makrinou","year":"2020","unstructured":"Makrinou E, Drong A, Christopoulos W, Lerner G, Chapa-Chorda A, Karaderi I, Lavery T, Hardy S, Lindgren K, Franks S. Genome-wide methylation profiling in granulosa lutein cells of women with Polycystic Ovary Syndrome (PCOS). Mol Cell Endocrinol. 2020;500:110611. https:\/\/doi.org\/10.1016\/j.mce.2019.110611.","journal-title":"Mol Cell Endocrinol"},{"key":"1789_CR123","doi-asserted-by":"publisher","unstructured":"Wang Y, Gao X, Yang Z, Yan X, He X, Guo T, Zhao S, Zhao H, Chen ZJ. Deciphering the DNA methylome in women with PCOS diagnosed using the new international evidence-based guidelines. Human Reprod. 2023;38 (Suppl. 2):ii69\u2013ii79. https:\/\/doi.org\/10.1093\/humrep\/dead191.","DOI":"10.1093\/humrep\/dead191"},{"issue":"3","key":"1789_CR124","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.fertnstert.2020.09.009","volume":"115","author":"KW Olsen","year":"2021","unstructured":"Olsen KW, Castillo-Fernandez J, Chan AC, Freiesleben NC, Zedeler A, Bungum M, Cardona A, Perry JRB, Skouby SO, Hoffmann ER, Kelsey G, Gr\u00f8ndahl ML. Identification of a unique epigenetic profile in women with diminished ovarian reserve. Fertil Steril. 2021;115(3):732\u201341. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.09.009.","journal-title":"Fertil Steril"},{"issue":"5","key":"1789_CR125","doi-asserted-by":"publisher","first-page":"e64801","DOI":"10.1371\/journal.pone.0064801","volume":"8","author":"HR Shen","year":"2013","unstructured":"Shen HR, Qiu LH, Zhang ZQ, Qin YY, Cao C, Di W. Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome. PLoS One. 2013;8(5):e64801. https:\/\/doi.org\/10.1371\/journal.pone.0064801.","journal-title":"PLoS One"},{"key":"1789_CR126","doi-asserted-by":"publisher","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16:9.1\u20139.17. https:\/\/doi.org\/10.1186\/s13048-022-01091-0.","DOI":"10.1186\/s13048-022-01091-0"},{"issue":"8","key":"1789_CR127","doi-asserted-by":"publisher","first-page":"e1005455","DOI":"10.1371\/journal.pgen.1005455","volume":"11","author":"MR Jones","year":"2015","unstructured":"Jones MR, Brower MA, Xu N, Cui J, Mengesha E, Chen YDI, Taylor KD, Azziz R, Goodarzi MO. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLOS Genet. 2015;11(8):e1005455. https:\/\/doi.org\/10.1371\/journal.pgen.1005455.","journal-title":"PLOS Genet"},{"key":"1789_CR128","doi-asserted-by":"publisher","unstructured":"Pan JX, Tan YJ, Wang FF, Hou NN, Xiang YQ, Zhang JY, Liu Y, Qu F, Meng Q, Xu J, Sheng JZ, Huang HF. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis. Clin Epigenet. 2018;10:6.1\u20136.12. https:\/\/doi.org\/10.1186\/s13148-018-0442-y.","DOI":"10.1186\/s13148-018-0442-y"},{"issue":"9","key":"1789_CR129","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1002\/jcp.30309","volume":"236","author":"Z Mao","year":"2021","unstructured":"Mao Z, Li T, Zhao H, Wang X, Kang Y, Kang Y. Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome. J Cell Physiol. 2021;236(9):6362\u201375. https:\/\/doi.org\/10.1002\/jcp.30309.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1789_CR130","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2741\/e829","volume":"10","author":"P Sagvekar","year":"2018","unstructured":"Sagvekar P, Dadachanji R, Patil K, Mukherjee S. Pathomechanisms of polycystic ovary syndrome: multidimensional approaches. Front Biosci (Elite edition). 2018;10(3):384\u2013422. https:\/\/doi.org\/10.2741\/e829.","journal-title":"Front Biosci (Elite edition)"},{"issue":"5","key":"1789_CR131","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2023.02.007","volume":"86","author":"F Qin","year":"2023","unstructured":"Qin F, Li B, Wang H, Ma S, Li J, Liu S, Kong L, Zheng H, Zhu R, Han Y, Yang M, Li K, Ji X, Chen PR. Linking chromatin acylation mark-defined proteome and genome in living cells. Cell. 2023;86(5):1066-1085.e36. https:\/\/doi.org\/10.1016\/j.cell.2023.02.007.","journal-title":"Cell"},{"key":"1789_CR132","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41589-023-01309-2","volume":"19","author":"Y Song","year":"2023","unstructured":"Song Y. One-site \u2018-omics.\u2019 Nat Chem Biol. 2023;19:391. https:\/\/doi.org\/10.1038\/s41589-023-01309-2.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"1789_CR133","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1074\/mcp.m200025-mcp200","volume":"1","author":"SE Ong","year":"2002","unstructured":"Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1(5):376\u201386. https:\/\/doi.org\/10.1074\/mcp.m200025-mcp200.","journal-title":"Mol Cell Proteomics"},{"key":"1789_CR134","doi-asserted-by":"publisher","unstructured":"Ninova M, Fejes T\u00f3th K, Aravin AA. The control of gene expression and cell identity by H3K9 trimethylation. Development (Cambridge, England). 2019;146(19):dev181180. https:\/\/doi.org\/10.1242\/dev.181180.","DOI":"10.1242\/dev.181180"},{"key":"1789_CR135","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41580-019-0151-1","volume":"20","author":"A Jambhekar","year":"2019","unstructured":"Jambhekar A, Dhall A, Shi Y. Roles and regulation of histone methylation in animal development. Nat Rev Mol Cell Biol. 2019;20:625\u201341. https:\/\/doi.org\/10.1038\/s41580-019-0151-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1789_CR136","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41573-020-00108-x","volume":"20","author":"KP Bhat","year":"2021","unstructured":"Bhat KP, Kaniskan UH, Jin J, Gozani O. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat Rev Drug Discov. 2021;20:265\u201386. https:\/\/doi.org\/10.1038\/s41573-020-00108-x.","journal-title":"Nat Rev Drug Discov"},{"key":"1789_CR137","doi-asserted-by":"publisher","first-page":"1024320","DOI":"10.3389\/fendo.2022.1024320","volume":"13","author":"H Wei","year":"2022","unstructured":"Wei H, Huo P, Liu S, Huang H, Zhang S. Posttranslational modifications in pathogenesis of PCOS. Front Endocrinol. 2022;13:1024320. https:\/\/doi.org\/10.3389\/fendo.2022.1024320.","journal-title":"Front Endocrinol"},{"key":"1789_CR138","doi-asserted-by":"publisher","first-page":"887","DOI":"10.5114\/aoms.2019.86060","volume":"15","author":"E Hosseini","year":"2019","unstructured":"Hosseini E, Shahhoseini M, Afsharian P, Karimian L, Ashrafi M, Mehraein F. Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome. Arch Med Sci. 2019;15:887\u201395. https:\/\/doi.org\/10.5114\/aoms.2019.86060.","journal-title":"Arch Med Sci"},{"key":"1789_CR139","doi-asserted-by":"publisher","unstructured":"Roy S, Abudu A, Salinas I, Sinha N, Cline-Fedewa H, Yaw AM. Androgen-mediated perturbation of the hepatic circadian system through epigenetic modulation promotes NAFLD in PCOS mice. Endocrinol. 2022;163(10):bqac127. https:\/\/doi.org\/10.1210\/endocr\/bqac127.","DOI":"10.1210\/endocr\/bqac127"},{"issue":"5","key":"1789_CR140","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/biolre\/ioaa007","volume":"102","author":"N Sinha","year":"2020","unstructured":"Sinha N, Roy S, Huang B, Wang J, Padmanabhan V, Sen A. Developmental programming: prenatal testosterone-induced epigenetic modulation and its effect on gene expression in sheep ovary. Biol Reprod. 2020;102(5):1045\u201354. https:\/\/doi.org\/10.1093\/biolre\/ioaa007.","journal-title":"Biol Reprod"},{"key":"1789_CR141","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1210\/en.2019-00389","volume":"160","author":"X Guo","year":"2019","unstructured":"Guo X, Puttabyatappa M, Thompson RC, Padmanabhan V. Developmental programming: contribution of epigenetic enzymes to antral follicular defects in the sheep model of PCOS. Endocrinol. 2019;160:2471\u201384. https:\/\/doi.org\/10.1210\/en.2019-00389.","journal-title":"Endocrinol"},{"key":"1789_CR142","doi-asserted-by":"publisher","unstructured":"Norris KL, Lee JY, Yao TP. Acetylation goes global: the emergence of acetylation biology. Sci Signal. 2009;2(97):pe76. https:\/\/doi.org\/10.1126\/scisignal.297pe76.","DOI":"10.1126\/scisignal.297pe76"},{"key":"1789_CR143","doi-asserted-by":"publisher","first-page":"567028","DOI":"10.3389\/fcell.2020.567028","volume":"8","author":"Z Min","year":"2020","unstructured":"Min Z, Long X, Zhao H, Zhen X, Li R, Li M, Fan Y, Yu Y, Zhao Y, Qiao J. Protein lysine acetylation in ovarian granulosa cells affects metabolic homeostasis and clinical presentations of women with polycystic ovary syndrome. Front Cell Dev Biol. 2020;8:567028. https:\/\/doi.org\/10.3389\/fcell.2020.567028.","journal-title":"Front Cell Dev Biol"},{"key":"1789_CR144","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1071\/RD16428","volume":"29","author":"F Eini","year":"2017","unstructured":"Eini F, Novin MG, Joharchi K, Ahmad H, Hamid N, Abbas P, Bidadkosh A. Intracytoplasmic oxidative stress reverses epigenetic modifications in polycystic ovary syndrome. Reprod Fertil Dev. 2017;29:2313\u201323. https:\/\/doi.org\/10.1071\/RD16428.","journal-title":"Reprod Fertil Dev"},{"issue":"8","key":"1789_CR145","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/mrd.23222","volume":"86","author":"F Eini","year":"2019","unstructured":"Eini F, Bidadkosh A, Nazarian H, Piryaei A, Novin MG, Joharchi K. Thymoquinone reduces intracytoplasmic oxidative stress and improves epigenetic modification in polycystic ovary syndrome mice oocytes, during in-vitro maturation. Mol Reprod Dev. 2019;86(8):1053\u201366. https:\/\/doi.org\/10.1002\/mrd.23222.","journal-title":"Mol Reprod Dev"},{"key":"1789_CR146","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbrc.2020.02.065","volume":"525","author":"CJ Yu","year":"2020","unstructured":"Yu CJ, Liu X, Zhou ZY, Chen XJ, Meng YC, Gu HC, Xu JJ, Ding GL, Liu XM, Sheng JZ, Huang HF. The casein kinase 2\u03b1 promotes the occurrence polycystic ovary syndrome. Biochem Biophys Res Commun. 2020;525:121\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.065.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1789_CR147","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/humrep\/deaa077","volume":"35","author":"J Jin","year":"2020","unstructured":"Jin J, Ma Y, Tong X, Yang W, Dai Y, Pan Y, Ren P, Liu L, Fan HY, Zhang Y, Zhang S. Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Hum Reprod. 2020;35(5):1145\u201358. https:\/\/doi.org\/10.1093\/humrep\/deaa077.","journal-title":"Hum Reprod"},{"key":"1789_CR148","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cell.2005.07.031","volume":"122","author":"S Bagga","year":"2005","unstructured":"Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005;122:553\u201363. https:\/\/doi.org\/10.1016\/j.cell.2005.07.031.","journal-title":"Cell"},{"issue":"4","key":"1789_CR149","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/cvr\/cvr268","volume":"93","author":"B Schroen","year":"2012","unstructured":"Schroen B, Heymans S. Small but smart\u2013microRNAs in the center of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc Res. 2012;93(4):605\u201313. https:\/\/doi.org\/10.1093\/cvr\/cvr268.","journal-title":"Cardiovasc Res"},{"key":"1789_CR150","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.gene.2019.04.082","volume":"706","author":"B Chen","year":"2019","unstructured":"Chen B, Xu P, Wang J, Zhang C. The role of MiRNA in Polycystic Ovary Syndrome (PCOS). Gene. 2019;706:91\u20136. https:\/\/doi.org\/10.1016\/j.gene.2019.04.082.","journal-title":"Gene"},{"key":"1789_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TACG.S207491","volume":"13","author":"B Kamalidehghan","year":"2020","unstructured":"Kamalidehghan B, Habibi M, Afjeh SS, Shoai M, Alidoost S, Almasi Ghale R, Eshghifar N, Pouresmaeili F. The importance of small non-coding RNAs in human reproduction: a review article. Appl Clin Genet. 2020;13:1\u201311. https:\/\/doi.org\/10.2147\/TACG.S207491.","journal-title":"Appl Clin Genet"},{"issue":"2","key":"1789_CR152","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10815-020-02019-7","volume":"38","author":"Y Luo","year":"2021","unstructured":"Luo Y, Cui C, Han X, Wang Q, Zhang C. The role of miRNAs in polycystic ovary syndrome with insulin resistance. J Assist Reprod Genet. 2021;38(2):289\u2013304. https:\/\/doi.org\/10.1007\/s10815-020-02019-7.","journal-title":"J Assist Reprod Genet"},{"key":"1789_CR153","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3892\/etm.2021.9790","volume":"21","author":"Y Wei","year":"2021","unstructured":"Wei Y, Wang Z, Wei L, Li S, Qiu X, Liu C. MicroRNA-874-3p promotes testosterone-induced granulosa cell apoptosis by suppressing HDAC1-mediated p53 deacetylation. Exp Ther Med. 2021;21:359. https:\/\/doi.org\/10.3892\/etm.2021.9790.","journal-title":"Exp Ther Med"},{"issue":"7","key":"1789_CR154","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1210\/jc.2013-1715","volume":"98","author":"Q Sang","year":"2013","unstructured":"Sang Q, Yao Z, Wang H, Feng R, Wang H, Zhao X, Xing Q, Jin L, He L, Wu L, Wang L. Identification of MicroRNAs in human follicular fluid: characterization of MicroRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab. 2013;98(7):3068\u201379. https:\/\/doi.org\/10.1210\/jc.2013-1715.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1789_CR155","doi-asserted-by":"publisher","first-page":"16306","DOI":"10.1038\/s41598-019-52856-5","volume":"9","author":"AE Butler","year":"2019","unstructured":"Butler AE, Ramachandran V, Hayat S, Dargham SR, Cunningham TK, Benurwar M, Sathyapalan T, Najafi-Shoushtari SH, Atkin SL. Expression of microRNA in follicular fluid in women with and without PCOS. Sci Rep. 2019;9(1):16306. https:\/\/doi.org\/10.1038\/s41598-019-52856-5.","journal-title":"Sci Rep"},{"key":"1789_CR156","doi-asserted-by":"publisher","unstructured":"Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, Wang L, Zhang Y, Liang X, Wang L, Gonzalez FJ, Patterson AD, Liu H, Mu L, Zhou Z, Zhao Y, Li R, Liu P, Zhong C, Pang Y, Jiang C, Qiao J. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225-33https:\/\/doi.org\/10.1038\/s41591-019-0509-0. Erratum in: Nat Med 25(9):1459.","DOI":"10.1038\/s41591-019-0509-0"},{"key":"1789_CR157","doi-asserted-by":"publisher","first-page":"1142041","DOI":"10.3389\/fcimb.2023.1142041","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gao S, Ye C, Zhao W. Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol. 2023;13:1142041. https:\/\/doi.org\/10.3389\/fcimb.2023.1142041.","journal-title":"Front Cell Infect Microbiol"},{"key":"1789_CR158","doi-asserted-by":"publisher","unstructured":"Yu L, Chen X, Bai X, Fang J, Sui M. Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients. Mol Neurobiol (Online ahead of print) 2023. https:\/\/doi.org\/10.1007\/s12035-023-03744-7.","DOI":"10.1007\/s12035-023-03744-7"},{"key":"1789_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.08.018","volume":"359","author":"J Roessler","year":"2022","unstructured":"Roessler J, Leistner DM, Landmesser U, Haghikia A. Modulatory role of gut microbiota in cholesterol and glucose metabolism: potential implications for atherosclerotic cardiovascular disease. Atherosclerosis. 2022;359:1\u201312. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.08.018.","journal-title":"Atherosclerosis"},{"key":"1789_CR160","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12916-023-02975-8","volume":"21","author":"P Li","year":"2023","unstructured":"Li P, Shuai P, Shen S, Zheng H, Sun P, Zhang R, Lan S, Lan Z, Jayawardana T, Yang Y, Zhao J, Liu Y, Chen X, El-Omar EM, Wan Z. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Med. 2023;21:302. https:\/\/doi.org\/10.1186\/s12916-023-02975-8.","journal-title":"BMC Med"},{"key":"1789_CR161","doi-asserted-by":"publisher","first-page":"808508","DOI":"10.3389\/fendo.2022.808508","volume":"13","author":"YY Gu","year":"2022","unstructured":"Gu YY, Zhou GN, Zhou FY, Li Y, Wu QW, He HY, Zhang Y, Ma C, Ding J, Hua K. Gut and vaginal microbiomes in PCOS: implications for women\u2019s health. Front Endocrinol. 2022;13:808508. https:\/\/doi.org\/10.3389\/fendo.2022.808508.","journal-title":"Front Endocrinol"},{"key":"1789_CR162","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3390\/biology11111683","volume":"11","author":"R Siddiqui","year":"2022","unstructured":"Siddiqui R, Makhlouf Z, Alharbi AM, Alfahemi H, Khan NA. The gut microbiome and female health. Biol (Basel). 2022;11:1683. https:\/\/doi.org\/10.3390\/biology11111683.","journal-title":"Biol (Basel)"},{"key":"1789_CR163","doi-asserted-by":"publisher","first-page":"933110","DOI":"10.3389\/fendo.2022.933110","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Hu R, Huang Y, Zhou F, Li F, Liu Z, Geng Y, Dong H, Ma W, Song K, Song Y. Present and future: crosstalks between polycystic ovary syndrome and gut metabolites relating to gut microbiota. Front Endocrinol (Lausanne). 2022;13:933110. https:\/\/doi.org\/10.3389\/fendo.2022.933110.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1789_CR164","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s43032-020-00430-0","volume":"29","author":"J Guo","year":"2021","unstructured":"Guo J, Shao J, Yang Y, Niu X, Liao J, Zhao Q, Wang D, Li S, Hu J. Gut microbiota in patients with polycystic ovary syndrome: a systematic review. Reprod Sci. 2021;29:69\u201383. https:\/\/doi.org\/10.1007\/s43032-020-00430-0.","journal-title":"Reprod Sci"},{"key":"1789_CR165","doi-asserted-by":"publisher","first-page":"112094","DOI":"10.1016\/j.biopha.2021.112094","volume":"142","author":"LY Duan","year":"2021","unstructured":"Duan LY, An XD, Zhang YH, Jin D, Zhao SH, Zhou RR, Duan Y, Zhang Y, Liu X, Lian F. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus. Biomed Pharmacother. 2021;142:112094. https:\/\/doi.org\/10.1016\/j.biopha.2021.112094.","journal-title":"Biomed Pharmacother"},{"key":"1789_CR166","doi-asserted-by":"publisher","unstructured":"Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I. Correlation of gut Firmicutes\/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci MicrobiotaFood Health. 2021;40(1):50\u201358. https:\/\/doi.org\/10.12938\/bmfh.2020-046.","DOI":"10.12938\/bmfh.2020-046"},{"issue":"5","key":"1789_CR167","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4093\/dmj.2019.0220","volume":"44","author":"Y Lee","year":"2020","unstructured":"Lee Y, Lee HY. Revisiting the bacterial phylum composition in metabolic diseases focused on host energy metabolism. Diabetes Metab J. 2020;44(5):658\u201367. https:\/\/doi.org\/10.4093\/dmj.2019.0220.","journal-title":"Diabetes Metab J"},{"issue":"11","key":"1789_CR168","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/microorganisms8111715","volume":"8","author":"S Stojanov","year":"2020","unstructured":"Stojanov S, Berlec A, \u0160trukelj B. The influence of probiotics on the firmicutes\/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 2020;8(11):1715. https:\/\/doi.org\/10.3390\/microorganisms8111715.","journal-title":"Microorganisms"},{"key":"1789_CR169","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12866-020-01903-7","volume":"20","author":"A Vaiserman","year":"2020","unstructured":"Vaiserman A, Romanenko M, Piven L, Moseiko V, Lushchak O, Kryzhanovska N, Guryanov V, Koliada A. Differences in the gut firmicutes to bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 2020;20:221. https:\/\/doi.org\/10.1186\/s12866-020-01903-7.","journal-title":"BMC Microbiol"},{"key":"1789_CR170","doi-asserted-by":"publisher","unstructured":"Rizk MG, Thackray VG. Intersection of polycystic ovary syndrome and the gut microbiome. J Endocrin Soc. 2021;5(2):bvaa177. https:\/\/doi.org\/10.1210\/jendso\/bvaa177.","DOI":"10.1210\/jendso\/bvaa177"},{"issue":"4","key":"1789_CR171","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.xfre.2023.08.009","volume":"4","author":"KI Sarkisian","year":"2023","unstructured":"Sarkisian KI, Ho L, Yang J, Mandelbaum R, Stanczyk FZ. Neuroendocrine, neurotransmitter, and gut microbiota imbalance contributing to potential psychiatric disorder prevalence in polycystic ovarian syndrome. F&S Rep. 2023;4(4):337\u201342. https:\/\/doi.org\/10.1016\/j.xfre.2023.08.009.","journal-title":"F&S Rep"},{"key":"1789_CR172","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19:371\u201384. https:\/\/doi.org\/10.1038\/s41576-018-0004-3.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"1789_CR173","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1093\/humrep\/deaa206","volume":"35","author":"BM Hanson","year":"2020","unstructured":"Hanson BM, Tao X, Zhan Y, Jenkins TG, Morin SJ, Scott RT, Seli EU. Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model. Hum Reprod. 2020;35(11):2579\u201388. https:\/\/doi.org\/10.1093\/humrep\/deaa206.","journal-title":"Hum Reprod"},{"key":"1789_CR174","doi-asserted-by":"publisher","unstructured":"Piani LL, Reschini M, Busnelli A, Fornelli G, Vigan\u00f2 P, Somigliana E. Epigenetic clock and endometriosis: A new rhythm for reproductive timeline? Hum. Reprod. 2022;37(Suppl-1):529. https:\/\/doi.org\/10.1093\/humrep\/deac104.043.","DOI":"10.1093\/humrep\/deac104.043"},{"issue":"3","key":"1789_CR175","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/humupd\/dmac042","volume":"29","author":"PI Deryabin","year":"2023","unstructured":"Deryabin PI, Borodkina AV. Epigenetic clocks provide clues to the mystery of uterine ageing. Hum Reprod Update. 2023;29(3):259\u201371. https:\/\/doi.org\/10.1093\/humupd\/dmac042.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"1789_CR176","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/genes14122132","volume":"14","author":"G Shacfe","year":"2023","unstructured":"Shacfe G, Turko R, Syed HH, Masoud I, Tahmaz Y, Samhan LM, Alkattan K, Shafqat A, Yaqinuddin A. A DNA methylation perspective on infertility. Genes. 2023;14(12):2132. https:\/\/doi.org\/10.3390\/genes14122132.","journal-title":"Genes"},{"issue":"7","key":"1789_CR177","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1210\/jc.2017-02751","volume":"103","author":"M Insenser","year":"2018","unstructured":"Insenser M, Murri M, Del Campo R. Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity. J Clin Endocrinol Metab. 2018;103(7):2552\u201362. https:\/\/doi.org\/10.1210\/jc.2017-02751.","journal-title":"J Clin Endocrinol Metab"},{"key":"1789_CR178","doi-asserted-by":"publisher","first-page":"e8317","DOI":"10.7717\/peerj.8317","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Sun H, Jiang F, Shen Y, Li X, Hu X, Shen X, Wei P. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing. PeerJ. 2020;8:e8317. https:\/\/doi.org\/10.7717\/peerj.8317.","journal-title":"PeerJ"},{"key":"1789_CR179","unstructured":"Janet Goins. Microbiomes: an origin story. 2019. Accessed from \u2018American Society for Microbiology\u2019 website https:\/\/asm.org\/Articles\/2019\/March\/Microbiomes-An-Origin-Story#."},{"issue":"1","key":"1789_CR180","doi-asserted-by":"publisher","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","volume":"12","author":"L Lindheim","year":"2017","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, Trummer C, Zachhuber V, Leber B, Horvath A, Pieber TR, Gorkiewicz G, Stadlbauer V, Obermayer-Pietsch B. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with Polycystic Ovary Syndrome (PCOS): a pilot study. PLoS One. 2017;12(1):e0168390. https:\/\/doi.org\/10.1371\/journal.pone.0168390.","journal-title":"PLoS One"},{"key":"1789_CR181","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3389\/fmicb.2016.01270","volume":"7","author":"L Lindheim","year":"2016","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, Trummer C, Zachhuber V, Pieber TR, Gorkiewicz G, Obermayer-Pietsch B. The salivary microbiome in Polycystic Ovary Syndrome (PCOS) and Its association with disease-related parameters: a pilot study. Front Microbiol. 2016;7:1270. https:\/\/doi.org\/10.3389\/fmicb.2016.01270.","journal-title":"Front Microbiol"},{"key":"1789_CR182","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fmicb.2017.00324","volume":"8","author":"R Liu","year":"2017","unstructured":"Liu R, Zhang C, Shi Y. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front Microbiol. 2017;8:324. https:\/\/doi.org\/10.3389\/fmicb.2017.00324.","journal-title":"Front Microbiol"},{"issue":"4","key":"1789_CR183","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1210\/jc.2017-02224","volume":"103","author":"PJ Torres","year":"2018","unstructured":"Torres PJ, Siakowska M, Banaszewska B. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism. J Clin Endocrinol Metab. 2018;103(4):1502\u201311. https:\/\/doi.org\/10.1210\/jc.2017-02224.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1789_CR184","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","volume":"79","author":"K Tremellen","year":"2012","unstructured":"Tremellen K, Pearce K. Dysbiosis of Gut Microbiota (DOGMA) \u2013 A novel theory for the development of polycystic ovarian syndrome. Med Hypotheses. 2012;79(1):104\u201312. https:\/\/doi.org\/10.1016\/j.mehy.2012.04.016.","journal-title":"Med Hypotheses"},{"key":"1789_CR185","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12881-019-0763-5","volume":"20","author":"XY Shi","year":"2019","unstructured":"Shi XY, Huang AP, Xie DW, Yu X-L. Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis. BMC Med Genet. 2019;20:32. https:\/\/doi.org\/10.1186\/s12881-019-0763-5.","journal-title":"BMC Med Genet"},{"issue":"1","key":"1789_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03000605221147444","volume":"51","author":"X Li","year":"2023","unstructured":"Li X, Wang C, Yang H, Pei D, Liu Y, Yan S, Li Y. Screening and verification of genes related to polycystic ovary syndrome. J Int Med Res. 2023;51(1):1\u201312. https:\/\/doi.org\/10.1177\/03000605221147444.","journal-title":"J Int Med Res"},{"key":"1789_CR187","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12863-015-0165-4","volume":"16","author":"R Guo","year":"2015","unstructured":"Guo R, Zheng Y, Yang J, Zheng N. Association of TNF-alpha, IL-6 and IL-1beta gene polymorphisms with polycystic ovary syndrome: a meta-analysis. BMC Genet. 2015;16:5. https:\/\/doi.org\/10.1186\/s12863-015-0165-4.","journal-title":"BMC Genet"},{"key":"1789_CR188","doi-asserted-by":"publisher","first-page":"110540","DOI":"10.1016\/j.mce.2019.110540","volume":"498","author":"Y Li","year":"2019","unstructured":"Li Y, Liu Y-D, Zhou X-Y, Chen S-L, Chen X, Zhe J, Zhang J, Zhang Q-Y, Chen Y-X. MiR-29a regulates the proliferation, aromatase expression, and estradiol biosynthesis of human granulosa cells in polycystic ovary syndrome. Mol Cell Endocrinol. 2019;498:110540. https:\/\/doi.org\/10.1016\/j.mce.2019.110540.","journal-title":"Mol Cell Endocrinol"},{"key":"1789_CR189","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, Zhang CM, Wang Y, Liu P, Tu BB, Zhang X, Qiao J. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153. https:\/\/doi.org\/10.1186\/1741-7015-10-153.","journal-title":"BMC Med"},{"issue":"1","key":"1789_CR190","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3892\/mmr.2018.9643","volume":"19","author":"X Fan","year":"2019","unstructured":"Fan X, Jiang J, Huang Z, Gong J, Wang Y, Xue W, Deng Y, Wang Y, Zheng T, Sun A, Luo G. UPLC\/Q-TOF-MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome. Mol Med Rep. 2019;19(1):280\u201392. https:\/\/doi.org\/10.3892\/mmr.2018.9643.","journal-title":"Mol Med Rep"},{"key":"1789_CR191","doi-asserted-by":"publisher","first-page":"960274","DOI":"10.3389\/fendo.2022.960274","volume":"13","author":"Y Ding","year":"2022","unstructured":"Ding Y, Jiang Y, Zhu M, Zhu Q, He Y, Lu Y, Wang Y, Qi J, Feng Y, Huang R, Yin H, Li S, Sun Y. Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: a pilot study. Front Endocrinol. 2022;13:960274. https:\/\/doi.org\/10.3389\/fendo.2022.960274.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1789_CR192","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/2213235X01666131203230512","volume":"2","author":"LD Whigham","year":"2014","unstructured":"Whigham LD, Butz DE, Dashti H, Tonelli M, Johnson LK, Cook ME, Porter WP, Eghbalnia HR, Markley JL, Lindheim SR, Schoeller DA, Abbott DH, Assadi-Porter FM. Metabolic evidence of diminished lipid oxidation in women with polycystic ovary syndrome. Curr Metabolomics. 2014;2(4):269\u201378. https:\/\/doi.org\/10.2174\/2213235X01666131203230512.","journal-title":"Curr Metabolomics"},{"key":"1789_CR193","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1039\/c6mb00420b","volume":"12","author":"S RoyChoudhury","year":"2016","unstructured":"RoyChoudhury S, Mishra BP, Khan T, Chattopadhayay R, Lodh I, Ray CD, Bose G, Sarkar HS, Srivastava S, Joshi MV, Chakravarty B, Chaudhury K. Serum metabolomics of Indian women with polycystic ovary syndrome using 1H NMR coupled with a pattern recognition approach. Mol BioSyst. 2016;12:3407\u201316. https:\/\/doi.org\/10.1039\/c6mb00420b.","journal-title":"Mol BioSyst"},{"key":"1789_CR194","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s12013-013-9602-z","volume":"67","author":"W Ting","year":"2013","unstructured":"Ting W, Yanyan Q, Jian H, Keqin H, Duan M. The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome. Cell Biochem Biophys. 2013;67:1041\u20137. https:\/\/doi.org\/10.1007\/s12013-013-9602-z.","journal-title":"Cell Biochem Biophys"},{"key":"1789_CR195","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2019.01.020","volume":"484","author":"W Zhu","year":"2019","unstructured":"Zhu W, Han B, Fan M, Wang N, Wang H, Zhu H, Cheng T, Zhao S, Song H, Qiao J. Oxidative stress increases the 17,20-lyase-catalyzing activity of adrenal P450c17 through p38\u03b1 in the development of hyperandrogenism. Mol Cell Endocrinol. 2019;484:25\u201333. https:\/\/doi.org\/10.1016\/j.mce.2019.01.020.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1789_CR196","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2011-07-369728","volume":"120","author":"KK Hosszu","year":"2012","unstructured":"Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce MG, Ji Y, Peerschke E, Ghebrehiwet B. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood. 2012;120(6):1228\u201336. https:\/\/doi.org\/10.1182\/blood-2011-07-369728.","journal-title":"Blood"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-01789-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T08:07:05Z","timestamp":1740816425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-01789-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":196,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-01789-8","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors of this article have made substantial contributions towards the conception and design of the work, acquisition, analysis, and interpretation of data; as well as for the preparation of draft and editing of the manuscript and approved the final version for submission.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors further declare that-i there are no financial or non-financial interests that are directly or indirectly related to the work submitted for publication,ii the work was not supported by any governmental or non-governmental financial institutions, andiii the authors declare no conflicting interests.iv informed consent is not required for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}